Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Diabetic Gastroparesis Treatment Global Market Report 2025
Request Sample Buy Now
Global Diabetic Gastroparesis Treatment Market Report 2025

Report Price : $4490.00

Pages : 200

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Diabetic Gastroparesis Treatment Global Market Report 2025

By Treatment (Medication, Surgery), By Route Of Administration (Oral, Injectables), By Indication (Compensated Gastroparesis, Gastric Failure), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels), By End User (Hospitals, Homecare, Specialty Clinics, Other End Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Diabetic Gastroparesis Treatment Market Overview

• Diabetic Gastroparesis Treatment market size has reached to $3.89 billion in 2024

• Expected to grow to $5.11 billion in 2029 at a compound annual growth rate (CAGR) of 6%

• Growth Driver: Rising Diabetes Prevalence Ignites Momentum In Diabetic Gastroparesis Treatment Market

• Market Trend: Innovative Medications Transforming The Landscape Of Diabetic Gastroparesis Treatment

• North America was the largest region in 2024.

What Is Covered Under Diabetic Gastroparesis Treatment Market?

Diabetic gastroparesis treatment involves managing delayed stomach emptying in diabetic patients, typically through medications like prokinetics, antiemetics, dietary changes, or, in severe cases, surgical interventions. These treatments aim to alleviate symptoms such as nausea, vomiting, and abdominal discomfort.

The main diabetic gastroparesis treatments are medication and surgery. Medications such as gastroprokinetic agents, antiemetic agents, and botulinum toxin are used to diagnose, treat, cure, prevent, or alleviate the symptoms of a medical condition or disease. These are administered as orals and injectables for the treatment of compensated gastroparesis and gastric failure. They are distributed by hospital pharmacies, retail pharmacies, and other channels for hospitals, homecare, specialty clinics, and others.

Diabetic Gastroparesis Treatment Market Size and growth rate 2025 to 2029: Graph

What Is The Diabetic Gastroparesis Treatment Market Size 2025 And Growth Rate?

The diabetic gastroparesis treatment market size has grown steadily in recent years. It will grow from $3.89 billion in 2024 to $4.05 billion in 2025 at a compound annual growth rate (CAGR) of 4.2%. The growth in the historic period can be attributed to increasing diabetes prevalence, limited treatment options, rising awareness and diagnosis, healthcare infrastructure development

What Is The Diabetic Gastroparesis Treatment Market Growth Forecast?

The diabetic gastroparesis treatment market size is expected to see strong growth in the next few years. It will grow to $5.11 billion in 2029 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to precision medicine and personalized therapies, growing diabetic population, increased research and development, shift in regulatory landscape. Major trends in the forecast period include technological innovations in treatments, emergence of novel therapies, focus on symptom management, telemedicine and remote monitoring, gut microbiome interventions.

The forecast of 6.0% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. gastroenterology care by inflating prices of gastric electrical stimulators and prokinetic drugs developed in Canada and Switzerland, resulting in prolonged digestive complications and higher gastrointestinal(GI) treatment costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Diabetic Gastroparesis Treatment Market Segmented?

1) By Treatment: Medication, Surgery

2) By Route Of Administration: Oral, Injectables

3) By Indication: Compensated Gastroparesis, Gastric Failure

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels

5) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

Subsegments:

1) By Medication: Prokinetic Agents, Antiemetics, antidepressants, Other Pharmacological Therapies

2) By Surgery: Gastric Electrical Stimulation, Surgical Procedures For Gastric Drainage, Other Surgical Interventions

What Is Driving The Diabetic Gastroparesis Treatment Market? Rising Diabetes Prevalence Ignites Momentum In Diabetic Gastroparesis Treatment Market

The increasing prevalence of diabetes is expected to propel the growth of the diabetic gastroparesis treatment market going forward. The prevalence of diabetes refers to the proportion or percentage of the population that has been diagnosed with diabetes at a specific point in time. The use of diabetic gastroparesis treatment is primarily aimed at managing the symptoms and complications associated with this condition, which is a common complication of diabetes. For instance, in April 2023, according to a report published by The British Diabetic Association, a UK-based diabetes charity, 4.3 million individuals in the UK have diabetes and live with it. Further, more than 2.4 million people in the UK are at high risk of acquiring type 2 diabetes, and registration numbers for 2021–22 are 148,951. Therefore, the increasing prevalence of diabetes is driving the growth of the diabetic gastroparesis treatment industry.

What Is Driving The Diabetic Gastroparesis Treatment Market? Rising Prediabetic Demographics Catalyst For Expansion In The Diabetic Gastroparesis Treatment Market

The increase in prediabetic population are expected to propel the growth of the diabetic gastroparesis treatment market going forward. Prediabetic population refers to individuals who have blood sugar levels that are higher than normal but not yet high enough to be diagnosed with diabetes. The growing number of individuals in the prediabetic stage underscores the importance of effective prevention and treatment strategies for diabetes and its complications, including gastroparesis. For instance, in June 2022, according to the data from Centers for Drug Control and Prevention, 96 million people aged 18 years or older have prediabetes (38.0% of the adult U.S. population). Therefore, the large prediabetic population is driving the growth of the diabetic gastroparesis treatment industry.

What Is Driving The Diabetic Gastroparesis Treatment Market? Surgical Advancements And Diabetic Gastroparesis Fueling Growth In Treatment Strategies

The rising number of surgical procedures is expected to propel the growth of the diabetic gastroparesis treatment market going forward. Surgery refers to a medical specialty and branch of medicine that involves the treatment of diseases, injuries, or conditions through operative procedures. Surgical procedures in diabetic patients that have caused post-surgical gastroparesis include Nissen fundoplication, gastrectomy, gastric bypass surgery, pancreatectomy, vagotomy, and cholecystectomy by injuring the vague nerve that coordinates food movement through the digestive tract. For instance, in October 2022, according to the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based professional body for board-certified aesthetic plastic surgeons, the total surgical and non-surgical procedures increased by 11.2% in 2022 with more than 14.9 million surgical and 18.8 million non-surgical procedures performed worldwide. Additionally, in September 2023, according to the American Society of Plastic Surgeons, a US-based plastic surgery specialty organization, the total cosmetic surgical procedures performed in 2022 were 1,498,361. Therefore, the rising number of surgical procedures drives the diabetic gastroparesis treatment industry.

Who Are The Major Players In The Global Diabetic Gastroparesis Treatment Market?

Major companies operating in the diabetic gastroparesis treatment market include Pfizer Inc., F. Hoffmann-La Roche Ltd., Ipca Laboratories Ltd., Abbott Laboratories, AstraZeneca plc, Medtronics plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Janssen Global Services LLC, Boston Scientific Corporation, Fresenius Kabi AG, Bausch Health Companies Inc., Salix Pharmaceuticals Inc., Ironwood Pharmaceuticals Inc., Wockhardt Ltd., ANI Pharmaceuticals Inc., Endologic LLC, Vanda Pharmaceuticals Inc., Rhythm Pharmaceuticals Inc., Theravance Biopharma Inc., Neurogastrx Inc., Evoke Pharma Inc., CinRx Pharma LLC

What Are The Key Trends Of The Global Diabetic Gastroparesis Treatment Market? Innovative Medications Transforming The Landscape Of Diabetic Gastroparesis Treatment

Developing new medications is a key trend gaining popularity in the diabetic gastroparesis treatment market. Major companies operating in the diabetic gastroparesis treatment market are developing new products to sustain their position in the market. For instance, in June 2023, The U.S. Food and Drug Administration, a US-based federal agency, approved two medications used for years to treat type 2 diabetes in adults and are now approved for use in kids ages ten and older. With the approval of Empagliflozin (Jardiance) and Synjardy (Empagliflozin and Metformin Hydrochloride), a new class of drugs for type 2 diabetes in children is now available. Combining empagliflozin and metformin in Synjardy is used to achieve better glycemic control in patients with type 2 diabetes. By combining two different mechanisms of action, Synjardy can provide more comprehensive blood sugar management than using either medication alone.

Global Diabetic Gastroparesis Treatment Market Trend: Avenacy Launches Metoclopramide Injection To Enhance Diabetic Gastroparesis Treatment

Major companies operating in the diabetic gastroparesis treatment market are innovating advanced solutions, such as small bowel intubation, to enhance diagnostic accuracy and treatment effectiveness. Small bowel intubation involves inserting a tube into the small intestine, enabling more precise monitoring and therapeutic interventions for conditions like diabetic gastroparesis, where gastric motility is impaired. For instance, in September 2024, Avenacy, a US-based pharmaceutical company launched Metoclopramide Injection (USP) in Unites States. Metoclopramide Injection (USP) is an injectable medication designed for multiple indications, notably including the relief of symptoms associated with diabetic gastroparesis. It helps prevent nausea and vomiting related to chemotherapy and surgery. The injection assists in small bowel intubation in cases where conventional methods fail to pass a tube through the pylorus. It is used to stimulate gastric emptying and facilitate barium transit during radiological procedures.

Need data on a specific region in this market?
Request Customisation

Regional Outlook For The Global Diabetic Gastroparesis Treatment Market

North America was the largest region in the diabetic gastroparesis treatment market in 2024, and is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

What Defines the Diabetic Gastroparesis Treatment Market?

The diabetic gastroparesis treatment market consists of revenues earned by entities by providing services such as medical evaluation, medication management, dietary consultation, insulin adjustment, lifestyle modifications, and support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The diabetic gastroparesis treatment market also includes sales of metoclopramide, erythromycin, domperidone, promethazine, and ondansetron (Zofran). Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Diabetic Gastroparesis Treatment Industry?

The diabetic gastroparesis treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the diabetic gastroparesis treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Diabetic Gastroparesis Treatment Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $4.05 billion
Revenue Forecast In 2034 $5.11 billion
Growth Rate CAGR of 6% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Treatment: Medication, Surgery
2) By Route Of Administration: Oral, Injectables
3) By Indication: Compensated Gastroparesis, Gastric Failure
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels
5) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users Subsegments: 1) By Medication: Prokinetic Agents, Antiemetics, Antidepressants, Other Pharmacological Therapies
2) By Surgery: Gastric Electrical Stimulation, Surgical Procedures For Gastric Drainage, Other Surgical Interventions
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., F. Hoffmann-La Roche Ltd., Ipca Laboratories Ltd., Abbott Laboratories, AstraZeneca plc, Medtronics plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Janssen Global Services LLC, Boston Scientific Corporation, Fresenius Kabi AG, Bausch Health Companies Inc., Salix Pharmaceuticals Inc., Ironwood Pharmaceuticals Inc., Wockhardt Ltd., ANI Pharmaceuticals Inc., Endologic LLC, Vanda Pharmaceuticals Inc., Rhythm Pharmaceuticals Inc., Theravance Biopharma Inc., Neurogastrx Inc., Evoke Pharma Inc., CinRx Pharma LLC
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Diabetic Gastroparesis Treatment Market Characteristics

3. Diabetic Gastroparesis Treatment Market Trends And Strategies

4. Diabetic Gastroparesis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Diabetic Gastroparesis Treatment Growth Analysis And Strategic Analysis Framework

5.1. Global Diabetic Gastroparesis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Diabetic Gastroparesis Treatment Market Growth Rate Analysis

5.4. Global Diabetic Gastroparesis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Diabetic Gastroparesis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Diabetic Gastroparesis Treatment Total Addressable Market (TAM)

6. Diabetic Gastroparesis Treatment Market Segmentation

6.1. Global Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Medication

Surgery

6.2. Global Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral

Injectables

6.3. Global Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Compensated Gastroparesis

Gastric Failure

6.4. Global Diabetic Gastroparesis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacies

Retail Pharmacies

Other Distribution Channels

6.5. Global Diabetic Gastroparesis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Homecare

Specialty Clinics

Other End Users

6.6. Global Diabetic Gastroparesis Treatment Market, Sub-Segmentation Of Medication, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Prokinetic Agents

Antiemetics

Antidepressants

Other Pharmacological Therapies

6.7. Global Diabetic Gastroparesis Treatment Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Gastric Electrical Stimulation

Surgical Procedures For Gastric Drainage

Other Surgical Interventions

7. Diabetic Gastroparesis Treatment Market Regional And Country Analysis

7.1. Global Diabetic Gastroparesis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Diabetic Gastroparesis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Diabetic Gastroparesis Treatment Market

8.1. Asia-Pacific Diabetic Gastroparesis Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Diabetic Gastroparesis Treatment Market

9.1. China Diabetic Gastroparesis Treatment Market Overview

9.2. China Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Diabetic Gastroparesis Treatment Market

10.1. India Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Diabetic Gastroparesis Treatment Market

11.1. Japan Diabetic Gastroparesis Treatment Market Overview

11.2. Japan Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Diabetic Gastroparesis Treatment Market

12.1. Australia Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Diabetic Gastroparesis Treatment Market

13.1. Indonesia Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Diabetic Gastroparesis Treatment Market

14.1. South Korea Diabetic Gastroparesis Treatment Market Overview

14.2. South Korea Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Diabetic Gastroparesis Treatment Market

15.1. Western Europe Diabetic Gastroparesis Treatment Market Overview

15.2. Western Europe Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Diabetic Gastroparesis Treatment Market

16.1. UK Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Diabetic Gastroparesis Treatment Market

17.1. Germany Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Diabetic Gastroparesis Treatment Market

18.1. France Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Diabetic Gastroparesis Treatment Market

19.1. Italy Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Diabetic Gastroparesis Treatment Market

20.1. Spain Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Diabetic Gastroparesis Treatment Market

21.1. Eastern Europe Diabetic Gastroparesis Treatment Market Overview

21.2. Eastern Europe Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Diabetic Gastroparesis Treatment Market

22.1. Russia Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Diabetic Gastroparesis Treatment Market

23.1. North America Diabetic Gastroparesis Treatment Market Overview

23.2. North America Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Diabetic Gastroparesis Treatment Market

24.1. USA Diabetic Gastroparesis Treatment Market Overview

24.2. USA Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Diabetic Gastroparesis Treatment Market

25.1. Canada Diabetic Gastroparesis Treatment Market Overview

25.2. Canada Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Diabetic Gastroparesis Treatment Market

26.1. South America Diabetic Gastroparesis Treatment Market Overview

26.2. South America Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Diabetic Gastroparesis Treatment Market

27.1. Brazil Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Diabetic Gastroparesis Treatment Market

28.1. Middle East Diabetic Gastroparesis Treatment Market Overview

28.2. Middle East Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Diabetic Gastroparesis Treatment Market

29.1. Africa Diabetic Gastroparesis Treatment Market Overview

29.2. Africa Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Diabetic Gastroparesis Treatment Market Competitive Landscape And Company Profiles

30.1. Diabetic Gastroparesis Treatment Market Competitive Landscape

30.2. Diabetic Gastroparesis Treatment Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Ipca Laboratories Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

30.2.5. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

31. Diabetic Gastroparesis Treatment Market Other Major And Innovative Companies

31.1. Medtronics plc

31.2. Takeda Pharmaceutical Company Limited

31.3. Eli Lilly and Company

31.4. Teva Pharmaceutical Industries Ltd.

31.5. Janssen Global Services LLC

31.6. Boston Scientific Corporation

31.7. Fresenius Kabi AG

31.8. Bausch Health Companies Inc.

31.9. Salix Pharmaceuticals Inc.

31.10. Ironwood Pharmaceuticals Inc.

31.11. Wockhardt Ltd.

31.12. ANI Pharmaceuticals Inc.

31.13. Endologic LLC

31.14. Vanda Pharmaceuticals Inc.

31.15. Rhythm Pharmaceuticals Inc.

32. Global Diabetic Gastroparesis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Diabetic Gastroparesis Treatment Market

34. Recent Developments In The Diabetic Gastroparesis Treatment Market

35. Diabetic Gastroparesis Treatment Market High Potential Countries, Segments and Strategies

35.1 Diabetic Gastroparesis Treatment Market In 2029 - Countries Offering Most New Opportunities

35.2 Diabetic Gastroparesis Treatment Market In 2029 - Segments Offering Most New Opportunities

35.3 Diabetic Gastroparesis Treatment Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Diabetic Gastroparesis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Diabetic Gastroparesis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Diabetic Gastroparesis Treatment Market, Sub-Segmentation Of Medication, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Diabetic Gastroparesis Treatment Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Diabetic Gastroparesis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Diabetic Gastroparesis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Pfizer Inc. Financial Performance
  • Table 79: F. Hoffmann-La Roche Ltd. Financial Performance
  • Table 80: Ipca Laboratories Ltd. Financial Performance
  • Table 81: Abbott Laboratories Financial Performance
  • Table 82: AstraZeneca plc Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Diabetic Gastroparesis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Diabetic Gastroparesis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Diabetic Gastroparesis Treatment Market, Sub-Segmentation Of Medication, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Diabetic Gastroparesis Treatment Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Diabetic Gastroparesis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Diabetic Gastroparesis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administartion, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Pfizer Inc. Financial Performance
  • Figure 79: F. Hoffmann-La Roche Ltd. Financial Performance
  • Figure 80: Ipca Laboratories Ltd. Financial Performance
  • Figure 81: Abbott Laboratories Financial Performance
  • Figure 82: AstraZeneca plc Financial Performance

Next-Gen Healthcare Services : Market Forecast, Transformation, and Long-Term Trajectories

Read More About Next-Gen Healthcare Services : Market Forecast, Transformation, and Long-Term Trajectories

Hospitals And Outpatient Care Centers Growth Trajectory: Key Forecasts and Strategic Insights

Read More About Hospitals And Outpatient Care Centers Growth Trajectory: Key Forecasts and Strategic Insights

ICU Beds Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Read More About ICU Beds Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Emerging Trends Redefining the ICU Beds Market Landscape: Innovative Products In Influenza Diagnostic Market Development

Read More About Emerging Trends Redefining the ICU Beds Market Landscape: Innovative Products In Influenza Diagnostic Market Development

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Read More About A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Read More About A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Tactical Communication Market 2023 – By Prodcut (Networking Radios, Multiband RadioSATCOM (Satellite Communication), Video Processors, Other Products), By Platform (Underwater Tactical Communication Systems, Airborne Tac...

View Report

Viral Vector Manufacturing Global Market Report 2025 – By Type (Adenoviral Vectors, Adeno-Associated Viral Vectors, Lentiviral Vectors, Retroviral Vectors, Other Types), By Disease (Cancer, Genetic Disorders, Infectious ...

View Report

Veterinary Orthopedic Medicine Global Market Report 2025 – By Product (Biologics, Viscosupplements, Pharmaceuticals), By Animal Type (Canine, Feline, Equine, Cattle, Swine, Other Animal Types), By Application (Osteoarthr...

View Report

Smart Retail Global Market Report 2025 – By System (Digital Signage Solutions, Smart Labels, Smart Payment Systems, Intelligent Vending Machines, Augmented Reality Solutions, Virtual Reality Solutions, Other Systems), By...

View Report

Tissue Sectioning Global Market Report 2025 – By Product (Accessories And Consumables, Instruments, Services), By Technology (Automatic, Manual, Semi-Automatic), By Application (Diagnosis, Research), By End-User (Clinics...

View Report

Geotourism Global Market Report 2025 – By Tour Type (Individual Travel, Professional Groups, Group Travels), By Tourism Type (Sustainable Tourism, Urban Geo-Tourism, Rural Geo-Tourism, Natural Tourism, Eco Geo-Tourism, O...

View Report

Simulation And Analysis Software Global Market Report 2025 – By Types (Finite Element Analysis Software (FEA), Computational Fluid Dynamics (CFD) Software, Other Types), By Deployment (On-Premise, Cloud-Based, Hybrid), B...

View Report

Geotourism Global Market Report 2025 – By Tour Type (Individual Travel, Professional Groups, Group Travels), By Tourism Type (Sustainable Tourism, Urban Geo-Tourism, Rural Geo-Tourism, Natural Tourism, Eco Geo-Tourism, O...

View Report

Frequently Asked Questions

Diabetic gastroparesis treatment involves managing delayed stomach emptying in diabetic patients, typically through medications like prokinetics, antiemetics, dietary changes, or, in severe cases, surgical interventions. These treatments aim to alleviate symptoms such as nausea, vomiting, and abdominal discomfort. For further insights on this market, request a sample here

The market major growth driver - Rising Diabetes Prevalence Ignites Momentum In Diabetic Gastroparesis Treatment Market. For further insights on this market, request a sample here

The diabetic gastroparesis treatment market size has grown steadily in recent years. It will grow from $3.89 billion in 2024 to $4.05 billion in 2025 at a compound annual growth rate (CAGR) of 4.2%. The growth in the historic period can be attributed to increasing diabetes prevalence, limited treatment options, rising awareness and diagnosis, healthcare infrastructure development. The diabetic gastroparesis treatment market size is expected to see strong growth in the next few years. It will grow to " $5.11 billion in 2029 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to precision medicine and personalized therapies, growing diabetic population, increased research and development, shift in regulatory landscape. Major trends in the forecast period include technological innovations in treatments, emergence of novel therapies, focus on symptom management, telemedicine and remote monitoring, gut microbiome interventions. For further insights on this market, request a sample here

The diabetic gastroparesis treatmentmarket covered in this report is segmented –
1) By Treatment: Medication; Surgery
2) By Route Of Administration: Oral; Injectables
3) By Indication: Compensated Gastroparesis; Gastric Failure
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Other Distribution Channels
5) By End User: Hospitals; Homecare; Specialty Clinics; Other End Users Subsegments:
1) By Medication: Prokinetic Agents; Antiemetics; Antidepressants; Other Pharmacological Therapies
2) By Surgery: Gastric Electrical Stimulation; Surgical Procedures For Gastric Drainage; Other Surgical Interventions For further insights on this market, request a sample here

North America was the largest region in the diabetic gastroparesis treatment market in 2024, and is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetic gastroparesis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on this market, request a sample here.

Major companies operating in the diabetic gastroparesis treatment market include Pfizer Inc., F. Hoffmann-La Roche Ltd., Ipca Laboratories Ltd., Abbott Laboratories, AstraZeneca plc, Medtronics plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Janssen Global Services LLC, Boston Scientific Corporation, Fresenius Kabi AG, Bausch Health Companies Inc., Salix Pharmaceuticals Inc., Ironwood Pharmaceuticals Inc., Wockhardt Ltd., ANI Pharmaceuticals Inc., Endologic LLC, Vanda Pharmaceuticals Inc., Rhythm Pharmaceuticals Inc., Theravance Biopharma Inc., Neurogastrx Inc., Evoke Pharma Inc., CinRx Pharma LLC . For further insights on this market, request a sample here.

Major trends in this market include Innovative Medications Transforming The Landscape Of Diabetic Gastroparesis Treatment. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Diabetic Gastroparesis Treatment Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon